Evidence map›Paper›PMID 40596546›Full record

ArticleScientific reports2025

Association of hemoglobin glycation index with all-cause and cardiovascular mortality in patients with diabetes or prediabetes and comorbid cardiovascular disease: a population-based cohort study.

Fachao Shi, Zhe Yang, Zheng Wang, Long Wang, Caoyang Fang

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fachao Shi *Department of Cardiology, Ma'anshan People's Hospital,Ma'anshan Hospital Affiliated to Wannan Medical College, Maanshan, 243000, Anhui, China.
Zhe Yang *Department of Emergency, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230000, Anhui, China.
Zheng Wang *Department of Cardiology, The Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, 230000, Anhui, China.
Long WangDepartment of Cardiology, The Second People's Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University, Hefei, 230000, Anhui, China.
Caoyang FangDepartment of Emergency, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230000, Anhui, China. 3408985159@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relationship between HGI and mortality in patients with diabetes or prediabetes who have comorbid CVD has not yet been clearly established. Therefore, the aim of this study was to investigate the correlation between baseline HGI and all-cause and cardiovascular mortality in US adults with diabetes or prediabetes and comorbid CVD. This study analyzed data from 1,760 patients with diabetes or prediabetes and comorbid CVD from the NHANES from 1999 to 2018. Three models were constructed considering covariates to evaluate the correlation between HGI and mortality risk. Additionally, we used RCS and threshold effects to analyze the nonlinear relationship. During the follow-up of 1,760 patients with diabetes or prediabetes and comorbid CVD, there were 793 all-cause deaths and 274 cardiovascular-related deaths recorded. Restricted cubic spline analysis results showed that baseline HGI was U-shapedly associated with all-cause and cardiovascular mortality rates. Threshold effect analysis indicated that the turning points of HGI for all-cause and cardiovascular mortality rates were - 0.382 and - 0.380, respectively. Specifically, when baseline HGI was below the turning point, HGI was negatively correlated with all-cause mortality rate (HR: 0.6, 95% CI: 0.5-0.7) and cardiovascular mortality rate (HR: 0.6, 95% CI: 0.4-1.0), while when baseline HGI exceeded the turning point, HGI was positively correlated with all-cause mortality rate (HR: 1.2, 95% CI: 1.1-1.4) and cardiovascular mortality rate (HR: 1.3, 95% CI: 1.1-1.5). We found that in US adults with diabetes or prediabetes and comorbid CVD, baseline HGI was U-shapedly associated with all-cause and cardiovascular mortality rates. Specifically, the turning points for all-cause and cardiovascular mortality rates were - 0.382 and - 0.380, respectively.

Indexed as

Cardiovascular DiseasesDiabetes MellitusGlycated HemoglobinPrediabetic StateAdultAgedCause of DeathCohort StudiesComorbidityFemaleHumansMaleMiddle AgedNutrition SurveysRisk FactorsUnited StatesGlycated HemoglobinAll-cause mortalityCardiovascular diseaseCardiovascular mortalityDiabetesHaemoglobin glycation indexHGIPre-diabetes

Identifiers

PMID40596546
PMCPMC12216783

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.